The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

New England Journal of Medicine

Volumn 345, Issue 9, 2001, Pages 656-661

  Barlow, William E ^a,b   Davis, Robert L ^a   Glasser, John W ^c   Rhodes, Phillip H ^c   Thompson, Robert S ^a   Mullooly, John P ^d   Black, Steven B ^e   Shinefield, Henry R ^e   Ward, Joel I ^f   Michael Marcy, S ^g   Destefano, Frank ^c   Immanuel, Virginia ^a   Pearson, John A ^d   Vadheim, Constance M ^f   Rebolledo, Viviana ^a   Christakis, Dimitri ^h   Benson, Patti J ^a   Lewis, Ned ^e   Chen, Robert T ^c  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e DIVISION OF RESEARCH   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g KAISER PERMANENTE   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE;

ARTICLE; CHILD; FEBRILE CONVULSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SEIZURE; VACCINATION;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MEASLES-MUMPS-RUBELLA VACCINE; PERTUSSIS VACCINE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK; SEIZURES; SEIZURES, FEBRILE;

EID: 0035975401     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa003077     Document Type: Article

References (27)

1. Vaccination against whooping cough
2. Severe neurological illness: Further analyses of the British National Childhood Encephalopathy Study
3. Neurologic events following diphtheria-tetanus-pertussis immunization
4. Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine
5. Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine: A population-based case-control study
6. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines
7. Risk of seizures after measles-mumps-rubella immunization
8. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States
9. Development and validation of an immunization tracking system in a large health maintenance organization
10. What have HMOs learned about clinical prevention services? An examination of the experience at Group Health Cooperative of Puget Sound
11. Immunization tracking systems: Experience of the CDC Vaccine Safety Datalink sites
12. Quality of HMO vaccination databases used to monitor childhood vaccine safety
13. Fitting Cox's proportional hazards models from survey data
14. Robust variance estimation for the case-cohort design
15. Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors
16. Perhaps it is not time to switch from whole cell to acellular pertussis vaccine
17. Time to switch from whole cell to acellular pertussis vaccines?
18. Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997
19. Public health considerations
20. Pertussis in Sweden after the cessation of general immunization in 1979
21. Measles virus infections of the central nervous system
22. Epidemiology of encephalitis in children: A prospective multicentre study
23. Long-term intellectual and behavioral outcomes of children with febrile convulsions
24. Febrile seizures and later intellectual performance
25. Surveillance of vaccine-related adverse events in the first year of life: A Manitoba cohort study
26. The Vaccine Adverse Event Reporting System (VAERS)